DWJ1248

· Daewoong Pharmaceutical Co. LTD.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for DWJ1248, covering 2022-06-15 to 2023-09-29. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of DWJ1248 With Remdesivir in Severe COVID-19 Patients [Phase 3]